Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia

被引:341
作者
Glaser, Stefan P. [1 ,2 ]
Lee, Erinna F. [1 ,2 ]
Trounson, Evelyn [1 ]
Bouillet, Philippe [1 ,2 ]
Wei, Andrew [3 ,4 ]
Fairlie, W. Douglas [1 ,2 ]
Izon, David J. [5 ]
Zuber, Johannes [6 ,7 ]
Rappaport, Amy R. [6 ,8 ]
Herold, Marco J. [1 ,2 ]
Alexander, Warren S. [1 ,2 ]
Lowe, Scott W. [6 ,8 ,9 ]
Robb, Lorraine [1 ,2 ]
Strasser, Andreas [1 ,2 ]
机构
[1] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia
[2] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia
[3] Alfred Hosp, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia
[4] Monash Univ, Melbourne, Vic 3004, Australia
[5] St Vincents Inst, Fitzroy, Vic 3065, Australia
[6] Cold Spring Harbor Labs, Cold Spring Harbor, NY 11724 USA
[7] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria
[8] Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA
[9] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA
基金
澳大利亚国家健康与医学研究理事会;
关键词
acute myeloid leukemia; apoptosis; Mcl-1; Bcl-x(L); MARROW-CELLS; STEM-CELLS; PROTEINS; GENE; CHEMOTHERAPY; EXPRESSION; SURVIVAL; BINDING; FAMILY; MICE;
D O I
10.1101/gad.182980.111
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Acute myeloid leukemia (AML) frequently relapses after initial treatment. Drug resistance in AML has been attributed to high levels of the anti-apoptotic Bcl-2 family members Bcl-x(L) and Mcl-1. Here we report that removal of Mcl-1, but not loss or pharmacological blockade of Bcl-x(L), Bcl-2, or Bcl-w, caused the death of transformed AML and could cure disease in AML-afflicted mice. Enforced expression of selective inhibitors of prosurvival Bcl-2 family members revealed that Mcl-1 is critical for survival of human AML cells. Thus, targeting of Mcl-1 or regulators of its expression may be a useful strategy for the treatment of AML.
引用
收藏
页码:120 / 125
页数:6
相关论文
共 30 条
[1]   Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells [J].
Allman, D ;
Karnell, FG ;
Punt, JA ;
Bakkour, S ;
Xu, LW ;
Myung, P ;
Koretzky, GA ;
Pui, JC ;
Aster, JC ;
Pear, WS .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (01) :99-106
[2]   A PRACTICAL SUMMARY OF SITE-SPECIFIC RECOMBINATION, CONDITIONAL MUTAGENESIS, AND TAMOXIFEN INDUCTION OF CREERT2 [J].
Anastassiadis, Konstantinos ;
Glaser, Stefan ;
Kranz, Andrea ;
Berhardt, Kaj ;
Stewart, A. Francis .
METHODS IN ENZYMOLOGY, VOL 477: GUIDE TO TECHNIQUES IN MOUSE DEVELOPMENT, PART B: MOUSE MOLECULAR GENETICS, SECOND EDITION, 2010, 477 :109-123
[3]   Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein [J].
Ayton, PM ;
Chen, EH ;
Cleary, ML .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (23) :10470-10478
[4]   The landscape of somatic copy-number alteration across human cancers [J].
Beroukhim, Rameen ;
Mermel, Craig H. ;
Porter, Dale ;
Wei, Guo ;
Raychaudhuri, Soumya ;
Donovan, Jerry ;
Barretina, Jordi ;
Boehm, Jesse S. ;
Dobson, Jennifer ;
Urashima, Mitsuyoshi ;
Mc Henry, Kevin T. ;
Pinchback, Reid M. ;
Ligon, Azra H. ;
Cho, Yoon-Jae ;
Haery, Leila ;
Greulich, Heidi ;
Reich, Michael ;
Winckler, Wendy ;
Lawrence, Michael S. ;
Weir, Barbara A. ;
Tanaka, Kumiko E. ;
Chiang, Derek Y. ;
Bass, Adam J. ;
Loo, Alice ;
Hoffman, Carter ;
Prensner, John ;
Liefeld, Ted ;
Gao, Qing ;
Yecies, Derek ;
Signoretti, Sabina ;
Maher, Elizabeth ;
Kaye, Frederic J. ;
Sasaki, Hidefumi ;
Tepper, Joel E. ;
Fletcher, Jonathan A. ;
Tabernero, Josep ;
Baselga, Jose ;
Tsao, Ming-Sound ;
Demichelis, Francesca ;
Rubin, Mark A. ;
Janne, Pasi A. ;
Daly, Mark J. ;
Nucera, Carmelo ;
Levine, Ross L. ;
Ebert, Benjamin L. ;
Gabriel, Stacey ;
Rustgi, Anil K. ;
Antonescu, Cristina R. ;
Ladanyi, Marc ;
Letai, Anthony .
NATURE, 2010, 463 (7283) :899-905
[5]   Polycystic kidney disease prevented by transgenic RNA interference [J].
Bouillet, P ;
Robati, M ;
Bath, M ;
Strasser, A .
CELL DEATH AND DIFFERENTIATION, 2005, 12 (07) :831-833
[6]   Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function [J].
Chen, L ;
Willis, SN ;
Wei, A ;
Smith, BJ ;
Fletcher, JI ;
Hinds, MG ;
Colman, PM ;
Day, CL ;
Adams, JM ;
Huang, DCS .
MOLECULAR CELL, 2005, 17 (03) :393-403
[7]   Acute myeloid leukaemia [J].
Estey, Elihu ;
Doehner, Hartmut .
LANCET, 2006, 368 (9550) :1894-1907
[8]   Enforced expression of the homeobox gene Mixl1 impairs hematopoietic differentiation and results in acute myeloid leukemia [J].
Glaser, Stefan ;
Metcalf, Donald ;
Wu, Li ;
Hart, Adam H. ;
DiRago, Ladina ;
Mifsud, Sandra ;
D'Amico, Angela ;
Dagger, Samantha ;
Campo, Chiara ;
Chan, Angela C. ;
Izon, David J. ;
Robb, Lorraine .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (44) :16460-16465
[9]   The histone 3 lysine 4 methyltransferase, Mll2, is only required briefly in development and spermatogenesis [J].
Glaser, Stefan ;
Lubitz, Sandra ;
Loveland, Kate L. ;
Ohbo, Kazu ;
Robb, Lorraine ;
Schwenk, Frieder ;
Seibler, Jost ;
Roellig, Daniela ;
Kranz, Andrea ;
Anastassiadis, Konstantinos ;
Stewart, A. Francis .
EPIGENETICS & CHROMATIN, 2009, 2
[10]   AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2 [J].
Jiao, B. ;
Wu, C-F ;
Liang, Y. ;
Chen, H-M ;
Xiong, S-M ;
Chen, B. ;
Shi, J-Y ;
Wang, Y-Y ;
Wang, J-H ;
Chen, Y. ;
Li, J-M ;
Gu, L-J ;
Tang, J-Y ;
Shen, Z-X ;
Gu, B-W ;
Zhao, W-L ;
Chen, Z. ;
Chen, S-J .
LEUKEMIA, 2009, 23 (09) :1598-1604